In Axia Growth's analysis of closed small-business sales, dermatology practices and medspas are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to American Med Spa Association (AmSpa), there were 10,488 U.S. medical spa locations in 2023, and only 3% were owned by private equity firms.
Dermatology is one of the most private-equity-penetrated physician specialties, with over 35 PE-backed platforms and an estimated 10% to 15% of private practices PE-backed. Advisers now expect a 'consolidation of consolidators.' Medspas are the opposite: 10,488 locations in 2023, 81% single-location, and only 3% owned by private equity firms. Public multiple data specific to either is thin, so buyers lean on platform comparables and disclosed deal terms.
Why published multiples differ
Published multiples differ mostly because they use different earnings and deal sizes. Small, owner-run businesses (under $2M of earnings) are priced on SDE, seller's discretionary earnings, which adds back the owner's pay, so SDE multiples are lower. From $2M of earnings up, buyers price on EBITDA, and multiples rise with size. Averages that mix sizes, or quote larger private-equity deals, read higher than a small-business sale.
Multiples by deal size
Sector: Healthcare. Median and middle half (p25-p75) of sale price to earnings.
Closed small-business sales in the Healthcare sector, by deal size. Axia Growth analysis of closed small-business sales, updated October 28, 2026.
Size band
n
Median multiple
p25-p75
Basis
Under $500K SDE
182
3.4x
2.7x-4.2x
SDE
$500K-$1M SDE
42
3.4x
2.5x-4.4x
SDE
$1M-$2M SDE
22
3.3x
2.7x-7.5x
SDE
$2M-$3M EBITDA
13
5.1x
3.1x-10.9x
EBITDA
$5M-$10M EBITDA
14
8.8x
3.4x-10.7x
EBITDA
$10M+ EBITDA
17
12.9x
9.4x-18.5x
EBITDA
Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of 2026-10-28. Methodology.
No published cell for the Healthcare size band: $3M-$5M EBITDA. Each has fewer than 10 closed sales, so Axia Growth does not estimate a multiple for it.
Selling a medspa to a private equity firm
Private equity buys medspas through platforms that add locations. Expect them to check provider licensing and supervision, membership and repeat-client revenue, and whether injectors stay after the sale. Price follows size: in Axia Growth's Healthcare sector data, businesses with under $500K of SDE sold for a median 3.4x SDE across 182 closed sales.
Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of October 28, 2026.
Dermatology practice EBITDA multiples by size
Smaller dermatology practices and medspas are priced on SDE, larger ones on EBITDA. Median sale multiples in Axia Growth's Healthcare sector data: Under $500K SDE, 3.4x (182 sales); $500K-$1M SDE, 3.4x (42 sales); $1M-$2M SDE, 3.3x (22 sales); and $10M+ EBITDA, 12.9x (17 sales). Every published size band is in the table on this page.
Source: Axia Growth analysis of 4,554 closed small-business sales over $500K, aggregated and de-identified. Data as of October 28, 2026.
Clean records on regulated services such as elective IV therapy, now subject to added rules in
some states.
Valuation and deal structure
Public multiple data specific to dermatology or medspas is thin. Most platform deals do not disclose
EBITDA, and public deal datasets do not break out either vertical. Smaller private deals generally
price below larger private-equity deals, so a single-location medspa should not expect a platform
multiple.
In Axia Growth's analysis of closed small-business sales, dermatology practices and medspas are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to American Med Spa Association (AmSpa), there were 10,488 U.S. medical spa locations in 2023, and only 3% were owned by private equity firms.
What multiple do dermatology practices and medspas sell for?
Axia Growth groups dermatology practices and medspas in the Healthcare sector, the closest published proxy: businesses with under $500K of SDE sold for a median 3.4x SDE across 182 sales (Axia Growth analysis of closed small-business sales, updated October 28, 2026).
SDE or EBITDA: which applies to my dermatology practice or medspa?
Axia Growth reports multiples of SDE (seller's discretionary earnings) for businesses with under $2M of earnings, where owner-operated businesses are usually priced, and multiples of EBITDA from $2M up, matching how buyers and brokers talk about deal size. For the Healthcare sector, Axia Growth publishes both SDE and EBITDA bands.
Enter your industry and annual earnings in the free business value calculator for a value range drawn from the same closed-sales data. The multiples by sector page shows every published size band.
In Axia Growth's analysis of closed small-business sales, dermatology practices and medspas are grouped in the Healthcare sector, where businesses with under $500K of SDE sold for a median 3.4x SDE (middle half 2.7x-4.2x) across 182 sales, updated October 28, 2026. According to American Med Spa Association (AmSpa), there were 10,488 U.S. medical spa locations in 2023, and only 3% were owned by private equity firms. Dermatology and medspa M&A in 2026: 10,488 U.S. medspas with only 3% PE-owned, 35+ PE-backed dermatology platforms, and state rules reshaping deal structure.
When using information from this guide, cite Axia Growth and link to this page.
Axia Growth LLC provides deal origination services and is not a registered broker-dealer, investment adviser, bank, or depository institution. Where Axia's compensation is contingent on closing, it relies on the M&A broker exemption (15 U.S.C. § 78o(b)(13)) and analogous state exemptions, where available. Axia is typically engaged and paid by the acquirer, does not represent sellers, and does not provide, arrange, or receive compensation for transaction financing. See full disclaimer: /legal/disclaimer